EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Distinct Associations of Age and CYP2D6 Genotype With Parent Venlafaxine Exposure and O‐Demethylation in Japanese Psychiatric Patients

Yugo Ishihara iD, Taro Sasaki, Tomohiro Asahi, Yujin Ono, Tomomi Sugisaki, Rina Hiramatsu, Yasushi Kawamata iD, Norio Sugawara iD, Norio Yasui-Furukori iD

Neuropsychopharmacology Reports · 2026-12 · 46 (4)

DOI: 10.1002/npr2.70175 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropsychopharmacology Reports, online erschienen am 29.10.2026. Verfasst von Yugo Ishihara und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Dokkyo Medical University School of Medicine, Tochigi, Japan. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP2D6, Mental Disorders, Venlafaxine Hydrochloride. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Venlafaxine (VEN) is converted to O‐desmethylvenlafaxine (ODV) mainly through CYP2D6‐mediated O‐demethylation. However, age‐related clinical factors may also influence VEN exposure in routine practice. We examined whether age and CYP2D6 genotype show different associations with parent‐drug exposure and metabolic conversion.

Methods

This retrospective therapeutic drug monitoring analysis included 78 Japanese psychiatric patients with available plasma VEN and ODV concentrations and CYP2D6 genotype data. Two prespecified outcomes were analyzed without body‐weight correction: VEN concentration divided by daily dose (VEN/dose) and the ODV/VEN ratio. CYP2D6*10 and *5 were coded as reduced‐ and no‐function alleles, respectively. Log‐transformed outcomes were analyzed using regression models including age and CYP2D6 reduced/no‐function allele count.

Results

Nineteen patients (24.4%) were aged 65 years or older. Age was correlated with VEN/dose (Spearman rho = 0.295, p = 0.0086), and older patients had higher VEN/dose than younger patients (median, 0.522 vs. 0.192 [ng/mL]/[mg/day], p = 0.0127). In regression analysis, the incremental R 2 for age was numerically larger than that for CYP2D6 allele count for VEN/dose (incremental R 2 , 0.058 vs. 0.026). Conversely, the ODV/VEN ratio was strongly associated with CYP2D6 allele count (standardized beta = −0.391, p < 0.001; incremental R 2 = 0.145) but not with age. Age‐by‐genotype interactions were not significant for either outcome.

Conclusions

Age appeared to be more closely related to dose‐corrected parent VEN exposure, whereas CYP2D6 genotype predominantly determined the ODV/VEN metabolic ratio. The relative contribution of age should be interpreted descriptively because no formal comparison of effect sizes was performed. Separating exposure and metabolic‐ratio outcomes may clarify how geriatric and pharmacogenetic factors contribute to VEN disposition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytochrome P-450 CYP2D6Mental DisordersVenlafaxine HydrochlorideAdultAgedFemaleHumansMaleMiddle AgedAge FactorsDesvenlafaxine SuccinateDrug MonitoringGenotypeJapanRetrospective StudiesYoung AdultAged, 80 and overEast Asian People

Stichwörter der Autor:innen

CYP2D6O‐desmethylvenlafaxineagingpharmacogeneticstherapeutic drug monitoringvenlafaxine

Substanzen

Cytochrome P-450 CYP2D6Desvenlafaxine SuccinateVenlafaxine Hydrochloride

Autor:innen und Institutionen

  • Department of Psychiatry, Dokkyo Medical University School of Medicine, Tochigi, Japan.

ORCID-Profile: Yugo Ishihara, Yasushi Kawamata, Norio Sugawara, Norio Yasui-Furukori

Zitieren

APA

Ishihara, Y., Sasaki, T., Asahi, T., Ono, Y., Sugisaki, T., Hiramatsu, R., Kawamata, Y., Sugawara, N., & Yasui-Furukori, N. (2026). Distinct Associations of Age and CYP2D6 Genotype With Parent Venlafaxine Exposure and O‐Demethylation in Japanese Psychiatric Patients. Neuropsychopharmacology Reports, 46(4). https://doi.org/10.1002/npr2.70175

Vancouver

Ishihara Y, Sasaki T, Asahi T, Ono Y, Sugisaki T, Hiramatsu R, et al. Distinct Associations of Age and CYP2D6 Genotype With Parent Venlafaxine Exposure and O‐Demethylation in Japanese Psychiatric Patients. Neuropsychopharmacology Reports. 2026;46(4). doi:10.1002/npr2.70175

BibTeX
@article{Ishihara2026,
  author = {Ishihara, Yugo and Sasaki, Taro and Asahi, Tomohiro and Ono, Yujin and Sugisaki, Tomomi and Hiramatsu, Rina and Kawamata, Yasushi and Sugawara, Norio and Yasui-Furukori, Norio},
  title = {Distinct Associations of Age and CYP2D6 Genotype With Parent Venlafaxine Exposure and O‐Demethylation in Japanese Psychiatric Patients},
  journal = {Neuropsychopharmacology Reports},
  year = {2026},
  volume = {46},
  number = {4},
  doi = {10.1002/npr2.70175}
}
Kostenlos starten →